Neuroone Medical Technologies (NMTC) FCF Margin Growth (3y) (2013 - 2026)
Neuroone Medical Technologies (NMTC) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 60.00 |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | 43,307.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43,307.00 |
| Mar 31, 2026 | 72,611.00 |
| Dec 31, 2025 | 294,882.00 |
| Sep 30, 2025 | -143,948.00 |
| Jun 30, 2025 | 830,722.00 |
| Mar 31, 2025 | 905,681.00 |
| Dec 31, 2024 | 812,647.00 |
| Sep 30, 2024 | 327,796.00 |
| Jun 30, 2024 | 549,681.00 |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 227,078.00 |
| Mar 31, 2015 | -1.36 Mn |
| Jun 30, 2014 | 15,645.00 |
| Mar 31, 2014 | 20,178.00 |
| Sep 30, 2013 | -13,120.00 |